| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027612 |
| Receipt No. | R000031642 |
| Scientific Title | A prospective study of preventive effect of tadalafil on urethral stricture after transurethral surgery |
| Date of disclosure of the study information | 2017/06/05 |
| Last modified on | 2021/06/06 (Ver. 5) |
| Basic information | ||
| Public title | A prospective study of preventive effect of tadalafil on urethral stricture after transurethral surgery | |
| Acronym | Preventive effect of tadalafil on urethral stricture after transurethral surgery | |
| Scientific Title | A prospective study of preventive effect of tadalafil on urethral stricture after transurethral surgery | |
| Scientific Title:Acronym | Preventive effect of tadalafil on urethral stricture after transurethral surgery | |
| Region |
|
|
| Condition | ||
| Condition | urethral stricture | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine preventive effect of tadalafil on urethral stricture after transurethral surgery |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Frequency of urethral stricture |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | tadarafil 5mg per day orally | |
| Interventions/Control_2 | no medication | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Male patients receiving transurethral surgery | |||
| Key exclusion criteria | NO user, allergy to tadalafil and ischemic heart disease | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokyo Metropolitan Police Hospital | ||||||
| Division name | Department of Urology | ||||||
| Zip code | 164-0001 | ||||||
| Address | 4-22-1, Nakano, Nakano-ku, Tokyo, Japan | ||||||
| TEL | 03-5343-5611 | ||||||
| hmatsu53@me.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokyo Metropolitan Police Hospital | ||||||
| Division name | Department of Urology | ||||||
| Zip code | 164-0001 | ||||||
| Address | 4-22-1, Nakano, Nakano-ku, Tokyo, Japan | ||||||
| TEL | 03-5343-5611 | ||||||
| Homepage URL | http://www.keisatsubyoin.or.jp/research.html | ||||||
| yakuzai@keisatsubyoin.or.jp | |||||||
| Sponsor | |
| Institute | Hisashi Matsushima
Tokyo Metropolitan Police Hospital Department of Urology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hisashi Matsushima
Tokyo Metropolitan Police Hospital Department of Urology |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | An Institutional Review Board in TMPH |
| Address | 4-22-1, Nakano, Nakano-ku, Tokyo, Japan |
| Tel | 03-5343-5611 |
| yakuzai@keisatsubyoin.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.keisatsubyoin.or.jp/research.html |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | http://www.keisatsubyoin.or.jp/research.html | ||||||
| Number of participants that the trial has enrolled | 60 | ||||||
| Results | Under investigation | ||||||
| Results date posted |
|
||||||
| Results Delayed |
|
||||||
| Results Delay Reason | Preparing to submit | ||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Patients receiving transurethral surgery for BPH | ||||||
| Participant flow | Finished | ||||||
| Adverse events | Nothing | ||||||
| Outcome measures | Risk factor of urethral stricture | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031642 |